iBio (IBIO) EV/EBITDA: History & Chart

iBio, Inc.(IBIO)

Biotechnology · San Diego, CA

$1.05-0.07 (-6.25%)

Delayed quote: Oct 6, 2026, 1:05 PM EDT

About iBio, Inc.

iBio, Inc., a United States-based biotechnology firm, delivers contract development and manufacturing (CDMO) services to its collaborators and external clients. Its operations are structured into two distinct segments: Biopharmaceuticals and Bioprocessing. The company's leading therapeutic candidate, IBIO-100, is currently progressing through investigational new drug (IND) development, aimed at addressing systemic scleroderma and idiopathic pulmonary fibrosis. Additionally, iBio is engaged in the preclinical development of vaccine candidates, including IBIO-200 and IBIO-201, designed to prevent severe acute respiratory syndrome coronavirus 2. Another candidate, IBIO-400, is in development for the treatment of classical swine fever. Beyond its proprietary pipeline, iBio provides recombinant proteins to third parties, available both as catalog items and custom-synthesized products. It also offers comprehensive services spanning process development, advanced manufacturing, filling and finishing, and bioanalytical support. iBio maintains several strategic partnerships: a licensing agreement with Planet Biotechnology, Inc. for infectious disease therapeutics; a collaborative effort with The Texas A&M University System focused on COVID-19 vaccine candidates; a licensing pact with the University of Natural Resources and Life Sciences, Vienna; and a collaboration with CC-Pharming Ltd. Its corporate headquarters are situated in Bryan, Texas.

San Diego, CA

23 employees

www.ibioinc.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Martin Brenner

View full financials

NAME	MARKET CAP	EV/EBITDA RATIO	TTM	3Y	5Y
iBio, Inc. (IBIO)	$67.52M	N/A	N/A	N/A	N/A
Fortress Biotech, Inc. (FBIO)vs ›	$67.93M	N/A	N/A	N/A	N/A
MindWalk Holdings Corp. (HYFT)vs ›	$69.31M	N/A	161.81x	161.81x	161.81x
Spero Therapeutics, Inc. (SPRO)vs ›	$69.19M	3.40x	7.89x	4.27x	4.27x
XBiotech Inc. (XBIT)vs ›	$65.85M	N/A	N/A	N/A	N/A
Cingulate Inc. (CING)vs ›	$65.46M	0.22x	0.03x	0.03x	0.03x
Champions Oncology, Inc. (CSBR)vs ›	$70.30M	264.31x	103.53x	75.29x	64.49x
InterCure Ltd. (INCR)vs ›	$65.15M	N/A	7.83x	18.88x	17.80x
Gossamer Bio, Inc. (GOSS)vs ›	$64.77M	N/A	N/A	N/A	N/A
Heron Therapeutics, Inc. (HRTX)vs ›	$64.56M	N/A	250.18x	250.18x	250.18x

NAME

MARKET CAP

EV/EBITDA RATIO

TTM

iBio, Inc. (IBIO)

$67.52M

N/A

Fortress Biotech, Inc. (FBIO)vs ›

$67.93M

N/A

MindWalk Holdings Corp. (HYFT)vs ›

$69.31M